Study 275: Updated Expanded Access Program for Remestemcel-L in Steroid-Refractory Acute Graft-versus-Host Disease in Children

Clinical outcomes in children with steroid-refractory acute graft-versus-host disease (SR-aGVHD) are generally poor, with a high mortality rate and limited therapeutic options. Here we report our updated investigational experience with mesenchymal stromal cell (MSC) therapy with remestemcel-L in a m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurtzberg, Joanne, Prockop, Susan, Chaudhury, Sonali, Horn, Biljana, Nemecek, Eneida, Prasad, Vinod, Satwani, Prakash, Teira, Pierre, Hayes, Jack, Burke, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292970/
https://www.ncbi.nlm.nih.gov/pubmed/32044400
http://dx.doi.org/10.1016/j.bbmt.2020.01.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292970/
https://www.ncbi.nlm.nih.gov/pubmed/32044400
http://dx.doi.org/10.1016/j.bbmt.2020.01.026

Ejemplares similares